CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+33.16%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$745M
AUM Growth
+$745M
(+4.9%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-7.88%
Top 10 Holdings %
Top 10 Hldgs %
91.04%
Holding
31
New
2
Increased
8
Reduced
11
Closed
9
Top Buys
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$56.7M |
| 2 |
LCI
Lannett Company, Inc.
LCI
|
$52.8M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$4.63M |
| 4 |
Orthofix Medical
OFIX
|
$2.46M |
| 5 |
OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
|
$2.13M |
Top Sells
| 1 |
AbbVie
ABBV
|
$39.6M |
| 2 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$36.9M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$20.6M |
| 4 |
INSY
Insys Therapeutics, Inc.
INSY
|
$19.7M |
| 5 |
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
|
$10.3M |
Sector Composition
| 1 | Healthcare | 90.18% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $125M | 16.73% | 1,406,137 +52,224 | +4% | +$4.63M |
|
|
INSY
2
DELISTED
Insys Therapeutics, Inc.
INSY
| $73.5M | 9.86% | 2,568,684 -688,410 | -21% | -$19.7M |
|
|
3
Orthofix Medical
OFIX
$592M
| $72.5M | 9.73% | 1,849,396 +62,861 | +4% | +$2.46M |
|
4
Pacific Biosciences
PACB
$393M
| $72.2M | 9.68% | 5,498,712 -759,149 | -12% | -$9.97M |
|
|
AKRX
5
DELISTED
Akorn, Inc.
AKRX
| $70.7M | 9.48% | 1,893,756 +20,000 | +1% | +$746K |
|
6
Travere Therapeutics
TVTX
$1.56B
| $66.8M | 8.95% | 3,460,323 +10,000 | +0.3% | +$193K |
|
|
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $56.7M | 7.61% | +760,000 | New | +$56.7M |
|
|
LCI
8
DELISTED
Lannett Company, Inc.
LCI
| $52.8M | 7.09% | +1,316,700 | New | +$52.8M |
|
|
9
AbbVie
ABBV
$372B
| $46.1M | 6.18% | 778,000 -667,900 | -46% | -$39.6M |
|
10
ANI Pharmaceuticals
ANIP
$2.03B
| $42.7M | 5.73% | 946,489 -109,800 | -10% | -$4.95M |
|
|
OSIR
11
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $23.3M | 3.12% | 2,240,709 +205,000 | +10% | +$2.13M |
|
12
Vanda Pharmaceuticals
VNDA
$279M
| $10.2M | 1.37% | 1,093,696 -343,100 | -24% | -$3.19M |
|
13
ADMA Biologics
ADMA
$4.12B
| $8.55M | 1.15% | 1,060,017 +7,875 | +0.7% | +$63.5K |
|
14
Catalyst Pharmaceutical
CPRX
$2.52B
| $7.08M | 0.95% | 2,888,942 -2,913,943 | -50% | -$7.14M |
|
15
Vericel Corp
VCEL
$1.83B
| $6.07M | 0.81% | 2,352,940 | – | – |
|
|
DSCI
16
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $4.28M | 0.57% | 937,516 -955,951 | -50% | -$4.37M |
|
|
SPNE
17
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.54M | 0.34% | 147,723 -100,779 | -41% | -$1.73M |
|
18
Axogen
AXGN
$743M
| $2.03M | 0.27% | 406,351 +181,951 | +81% | +$910K |
|
19
Veracyte
VCYT
$2.39B
| $1.19M | 0.16% | 165,825 -100,969 | -38% | -$727K |
|
|
BIOL
20
DELISTED
Biolase, Inc.
BIOL
| $922K | 0.12% | 1,096,092 -58,280 | -5% | -$49K |
|
|
CTIC
21
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $635K | 0.09% | 510,000 +50,000 | +11% | +$62.3K |
|
|
MSLI
22
DELISTED
Merus Labs International Inc.
MSLI
| $47K | 0.01% | 28,484 -1,275,000 | -98% | -$2.1M |
|
|
23
Enanta Pharmaceuticals
ENTA
$180M
| – | – | -570,662 | Closed | -$20.6M |
|
24
Lineage Cell Therapeutics
LCTX
$267M
| – | – | -539,640 | Closed | -$1.62M |
|
|
SIEN
25
DELISTED
Sientra, Inc.
SIEN
| – | – | -59,664 | Closed | -$606K |
|